Angiotensinogen and Risk of Stroke Events in Patients with Type 2 Diabetes Mellitus

References

• Roger VL, Go AS, Lloyd-Jones DM, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics–2011 update: a report from the American Heart Association. Circulation. 2011;123(4):e18–e209. doi:10.1161/CIR.0b013e3182009701
   PubMed Web of Science ®Google Scholar
• Selvin E, Juraschek SP, Coresh J. Kidney disease in people with diabetes: the expanding epidemic. Am J Kidney Dis. 2012;59(3):340–342. doi:10.1053/j.ajkd.2011.11.016
   Web of Science ®Google Scholar
• Foster MC, Rawlings AM, Marrett E, et al. Cardiovascular risk factor burden, treatment, and control among adults with chronic kidney disease in the United States. Am Heart J. 2013;166(1):150–156. doi:10.1016/j.ahj.2013.03.016
   PubMed Web of Science ®Google Scholar
• Di Angelantonio E, Kaptoge S, Wormser D, et al.; Emerging Risk Factors Collaboration. Association of cardiometabolic multimorbidity with mortality. JAMA. 2015;314(1):52–60. doi:10.1001/jama.2015.7008
   PubMed Web of Science ®Google Scholar
• Koya D, Araki S, Haneda M. Therapeutic management of diabetic kidney disease. J Diabetes Investig. 2011;2(4):248–254. doi:10.1111/j.2040-1124.2011.00112.x
   Web of Science ®Google Scholar
• Lewis EJ, Hunsicker LG, Clarke WR, et al.; Collaborative Study Group. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345(12):851–860. doi:10.1056/NEJMoa011303
   PubMed Web of Science ®Google Scholar
• Brenner BM, Cooper ME, de Zeeuw D, et al.; RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345(12):861–869. doi:10.1056/NEJMoa011161
   PubMed Web of Science ®Google Scholar
• Fried LF, Emanuele N, Zhang JH, et al.; VA NEPHRON-D Investigators. Combined angiotensin inhibition for the treatment of diabetic nephropathy. N Engl J Med. 2013;369(20):1892–1903. doi:10.1056/NEJMoa1303154
   PubMed Web of Science ®Google Scholar
• Ingelfinger JR, Zuo WM, Fon EA, Ellison KE, Dzau VJ. In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system. J Clin Invest. 1990;85(2):417–423. doi:10.1172/JCI114454
   PubMed Web of Science ®Google Scholar
• Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007;59(3):251–287. doi:10.1124/pr.59.3.3
   PubMed Web of Science ®Google Scholar
• Kobori H, Alper AB Jr, Shenava R, et al. Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients. Hypertension. 2009;53(2):344–350. doi:10.1161/HYPERTENSIONAHA.108.123802
   Web of Science ®Google Scholar
• Kobori H, Ohashi N, Katsurada A, et al. Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases. J Am Soc Hypertens. 2008;2(5):349–354. doi:10.1016/j.jash.2008.04.008
   Web of Science ®Google Scholar
• Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389(10085):2239–2251. doi:10.1016/S0140-6736(17)30058-2
   PubMed Web of Science ®Google Scholar
• Katsurada A, Hagiwara Y, Miyashita K, et al. Novel sandwich ELISA for human angiotensinogen. Am J Physiol Renal Physiol. 2007;293(3):F956–60. doi:10.1152/ajprenal.00090.2007
   Web of Science ®Google Scholar
• Krogh J, Benros ME, Martin Balslev J, et al. The association between depressive symptoms, cognitive function, and inflammation in major depression[J]. Brain Behav Immun. 2014;35(1):70–76. doi:10.1016/j.bbi.2013.08.014
   Web of Science ®Google Scholar
• Sawaguchi M, Araki SI, Kobori H, et al. Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus. J Diabetes Investig. 2012;3(3):318–324. doi:10.1111/j.2040-1124.2011.00172.x
   Web of Science ®Google Scholar
• Yasue S, Masuzaki H, Okada S, et al. Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophy. Am J Hypertens. 2010;23(4):425–431. doi:10.1038/ajh.2009.263
   PubMed Web of Science ®Google Scholar
• Kobori H, Nishiyama A, Harrison-Bernard LM, Navar LG. Urinary angiotensinogen as an indicator of intrarenal Angiotensin status in hypertension. Hypertension. 2003;41(1):42–49. doi:10.1161/01.HYP.0000050102.90932.CF
   Web of Science ®Google Scholar
• Ohashi N, Urushihara M, Satou R, Kobori H. Glomerular angiotensinogen is induced in mesangial cells in diabetic rats via reactive oxygen species–ERK/JNK pathways. Hypertens Res. 2010;33(11):1174–1181. doi:10.1038/hr.2010.143
   Web of Science ®Google Scholar
• Hsieh TJ, Zhang SL, Filep JG, Tang SS, Ingelfinger JR, Chan JS. High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. Endocrinology. 2002;143(8):2975–2985. doi:10.1210/endo.143.8.8931
   PubMed Web of Science ®Google Scholar
• Saito T, Urushihara M, Kotani Y, Kagami S, Kobori H. Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetes. Am J Med Sci. 2009;338(6):478–480. doi:10.1097/MAJ.0b013e3181b90c25
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Nakagawa T, Suzuki H, et al. Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease. J Am Soc Nephrol. 2007;18(5):1558–1565. doi:10.1681/ASN.2006060554
   PubMed Web of Science ®Google Scholar
• Annon CP, Perkovic V, Agarwal R, et al. Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7%: results from the credence trial. Circulation. 2020;141(5):407–410. doi:10.1161/CIRCULATIONAHA.119.044359
   Web of Science ®Google Scholar